Oct 31, 2025 9:50 PM Eastern Daylight Time TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Share LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tvardi Therapeutics, Inc. ("Tvardi†or "the Company†) (NASDAQ: TVRD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleadi ...